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Abstract Mitochondrial permeability transition (MPT) is a
non-selective inner membrane permeabilization that may precede
necrotic and apoptotic cell death. Although this process has a
specific inhibitor, cyclosporin A, little is known about the nature
of the proteinaceous pore that results in MPT. Here, we review
data indicating that MPT is not a consequence of the opening of
a pre-formed pore, but the consequence of oxidative damage to
pre-existing membrane proteins. ß 2001 Published by Elsevier
Science B.V. on behalf of the Federation of European Biochem-
ical Societies.
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1. Introduction
After the discovery that mitochondrial components, includ-
ing the apoptosis inducing factor and cytochrome c, can trig-
ger apoptosis [1^5], attention has concentrated on mechanisms
through which mitochondria control cell death. One of the
many processes that allow mitochondria to release apoptogen-
ic signal molecules into the cytosol is the occurrence of mito-
chondrial permeability transition (MPT) [3^5]. MPT is a non-
selective permeabilization of the inner mitochondrial mem-
brane typically promoted by the accumulation of excessive
quantities of Ca2 ions and stimulated by a variety of com-
pounds or conditions (for a review see [6]). The inner mem-
brane permeabilization caused by MPT results in loss of ma-
trix components, impairment of mitochondrial functionality
and substantial swelling of the organelle, with consequent out-
er membrane rupture and cytochrome c release [3,6,7].
Despite extensive research, the exact nature of the mem-
brane alterations that lead to MPT still remains unanswered.
Since MPT is a partially reversible process [8] mediated by
membrane protein thiol oxidation and inhibited by cyclospor-
in A [6], it clearly involves membrane proteins. However, no
novel inner membrane pore to date has shown MPT charac-
teristics. Instead, MPT is almost certainly caused by a group
of modi¢ed and assembled inner and outer membrane com-
ponents [9], including the ADP/ATP translocator, cyclophilin
D and, possibly, porin and hexokinase [10^13].
Another uncertainty involving MPT is the mechanism
through which normal components of mitochondria that par-
ticipate in MPT assemble to form a non-selective pore upon
excessive accumulation of Ca2. In this article, we review data
that strongly suggest that the link between excessive mito-
chondrial Ca2 accumulation and MPT is oxidative stress.
2. MPT can be induced by mitochondrial pyridine nucleotide
oxidation
Early experiments involving ruthenium red-insensitive mito-
chondrial Ca2 release (now attributable to MPT) showed
that this process could be stimulated by promoting the oxida-
tion of mitochondrial pyridine nucleotides, and inhibited or
reversed by NAD(P) reduction [14]. Subsequent data con-
¢rmed that NAD(P) redox status, manipulated through the
use of reductants and oxidants, regulated the onset of MPT
[10,15^20]. In addition, oxidation of NADPH was shown to
be more closely linked to MPT than that of NADH [21].
These ¢ndings were a ¢rst indication that MPT was related
to the redox state of mitochondria and could be caused by
reactive oxygen species (ROS), since NADPH plays a central
role in mitochondrial defense against oxidative stress. The
reductive e¡ect of NADPH on glutathione (GSH) and thio-
redoxin (TSH), which are substrates for mitochondrial gluta-
thione peroxidase (GPx) and thioredoxin peroxidase (TPx),
maintains the functionality of the main H2O2 removal en-
zymes in the organelle [22,23]. Moreover, in the absence of
adequate superoxide (O32 ) removal a further oxidation of
NAD(P)H could be caused by aconitase inhibition [24], inten-
sifying mitochondrial oxidative stress [25].
An interesting substantiation of the link between MPT and
the NAD(P) redox state is the e¡ect of the membrane poten-
tial in this process. As long as intramitochondrial Ca2 stores
are maintained high, large decreases in transmembrane elec-
trical potential stimulate MPT [15,17,18,20,26^28]. Increased
transmembrane electrical potentials, such as those observed in
cells overexpressing the anti-apoptotic protein Bcl-2, prevent
MPT [29]. This regulation of MPT is most probably mediated
by the e¡ects of membrane potential changes on the NAD(P)
redox status, as controlled by the membrane potential-sensi-
tive NADP transhydrogenase [22].
The indirect antioxidant e¡ect of the energy-linked NADP
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transhydrogenase may be an evolutionary defense against oxi-
dative stress, since high membrane potentials favor ROS gen-
eration [30]. High membrane potentials are accompanied by
slower respiratory rates, which stimulate ROS generation by
increasing O2 tension in the tissues and favoring longer life
spans of highly reactive intermediates of the electron transfer
chain such as semiquinone radicals [23,30]. Thus, ideal pro-
tection against oxidative stress should be obtained under con-
ditions of mild uncoupling (lowering the membrane potential
by W15 mV), when the reaction catalyzed by the NADP
transhydrogenase is still shifted toward generating NADPH,
but ROS generation is largely diminished [23,31].
3. MPT is promoted by thiol oxidation
Since NAD(P)H redox status is intimately associated with
GSH and mitochondrial protein thiol redox state [32], it is
logical to suppose that MPT is related to membrane protein
thiol status. Indeed, MPT is prevented by thiol reductants
such as dithiothreitol [9,33^35], while thiol oxidants such as
diamide, phenylarsine oxide and 4,4P-diisothiocyanato-stil-
bene-2,2P-disulfonic acid promote MPT [21,36,37]. Thiol oxi-
dants and reductants may regulate MPT both by controlling
mitochondrial GSH levels or by direct changes in the redox
state of MPT pore thiols. Interestingly, Costantini et al. [38]
have shown that two distinct membrane thiol pools regulate
the opening of the MPT pore, each with reactivity toward
distinct thiol reagents.
Thus, we now know that MPT occurs when thiol groups of
inner membrane proteins are oxidized, resulting in conforma-
tional changes that, somehow, form a large non-selective pore.
Interestingly, thiol cross-linkage seems to be essential for these
conformational changes, since only dithiol reagents promote
MPT. Indeed, cross-linked inner membrane proteins can be
observed after MPT on sodium dodecyl sulfate^polyacryl-
amide gel electrophoresis of solubilized membrane proteins
[8,9,35,39]. The proteins which must be cross-linked to result
in MPT have still not been determined, but most certainly
involve the ADP/ATP translocator [11,12]. In this regard,
Vercesi [10] showed evidence for the participation of the
ADP/ATP translocator and membrane protein thiol oxidation
in the mechanism of NADP-stimulated Ca2 release from
mitochondria. In addition, a critical cysteine residue (Cys56)
of the ADP/ATP translocator is oxidized in isolated mito-
chondria and cells which underwent MPT [40].
4. MPT is inhibited by antioxidants
Based on the evidence that MPT was stimulated by thiol
oxidation and depletion of mitochondrial NADPH, we de-
Fig. 1. Mitochondrial ROS accumulation causes MPT. The respiratory chain, inserted in the inner mitochondrial membrane, constantly gener-
ates small quantities of superoxide radicals (O32 ). These radicals are normally removed by Mn-superoxide dismutase (MnSOD), which pro-
motes the generation of H2O2. H2O2 is then reduced to water by GPx, TPx or catalase (in heart mitochondria). GSH, oxidized by GPx, and
TSH, oxidized by TPx, are recovered by glutathione and thioredoxin reductases (GR and TR), which use NADPH as an electron donor.
NADH, which is available in quantities regulated by respiration and Bcl-2, then reduces NADP, using the NADP transhydrogenase (TH).
When O32 generation increases in the presence of Ca
2 and Pi, and/or H2O2 removal pathways are inactivated, H2O2 accumulates in quantities
too large for removal, and, in the presence of Fe2, generates the highly reactive HO radical. HO oxidizes thiol (^SH) groups of the MPT
pore complex, leading to pore assembly and opening. Alternatively, HO may also promote membrane permeabilization through lipid oxida-
tion, a process strongly stimulated by Pi.
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cided to directly test the hypothesis that MPT was caused by
oxidative stress. Con¢rming our initial proposition, we ob-
served that a wide variety of antioxidants protect against
MPT [35,39,41^43]. The ¢nding that catalase and thiol peroxi-
dases protect against MPT was especially signi¢cant, since it
indicates that MPT can be induced directly by ROS, and
depends on the presence of H2O2. Mitochondrial H2O2 de-
rives from superoxide radicals (see Fig. 1) and is converted to
hydroxyl radicals, via the Fe2-dependent Fenton reaction,
before promoting MPT [39].
The obvious source of ROS production leading to MPT is
the mitochondrial respiratory chain. We have determined that
the semiquinone form of coenzyme Q is a signi¢cant generator
of superoxide radicals that ultimately promote MPT [44], and
that a decrease in the concentration of molecular oxygen in
the reaction medium protects against MPT [39]. Although the
pronounced inhibition of MPT in anaerobiosis supports the
participation of ROS in MPT, it is important to stress that
free radicals may be formed through electron donation to
components of the mitochondrial suspension even in the ab-
sence of oxygen [39]. These free radicals could be responsible
for MPT observed under anaerobic conditions [45,46]. How-
ever, we have also shown that full removal of molecular oxy-
gen from the mitochondrial suspension is not easily obtained
[43], explaining why ROS may be present under apparent
anaerobiosis. In the full absence of ROS, MPT appears to
be fully inhibited when promoted by Ca2 and inorganic
phosphate (Pi) or NAD(P)H oxidants [39,43], but may still
be promoted by direct oxidation of inner membrane protein
thiols using thiol reagents [21,36,37].
Further evidence that MPT was caused by ROS was pro-
vided by the discovery that this process could be promoted
through the addition of exogenous sources of ROS [47,48].
Nitrogen-containing ROS such as peroxynitrite cause protein
thiol oxidation and MPT, paralleled by membrane lipid oxi-
dation [49,50].
5. Ca2+ and Pi lead to mitochondrial oxidative stress
Protection against MPT conferred by antioxidants such as
catalase is observed not only when MPT is caused by
NAD(P)H oxidation, but also when MPT is induced by
Ca2 and Pi in the absence of NAD(P)H oxidants [41^43].
This ¢nding suggests that Ca2 and Pi can, alone, lead to a
condition of oxidative stress in mitochondria. Indeed, we mea-
sured a large increase in ROS generation when mitochondria
were treated with Ca2 and Pi [41^43]. To date, there is no
clear understanding why Pi, despite decreasing matrix free
Ca2 concentrations, increases ROS generation and stimulates
MPT. It is possible that Pi catalyzes reactions that favor ROS
formation (see below and [41]).
Grijalba et al. [51] have developed an interesting hypothesis,
supported by experimental data, to explain how Ca2 may
increase mitochondrial ROS formation. They demonstrated
that Ca2 alters the lipid organization of the inner mitochon-
drial membrane by interacting with the anionic head of car-
diolipin, an abundant component of this membrane. These
alterations in membrane organization may a¡ect respiratory
chain function, including coenzyme Q mobility, and favor
monoelectronic oxygen reduction (superoxide radical genera-
tion) at intermediate steps of the respiratory chain.
6. MPT can be associated with other forms of mitochondrial
oxidative damage
Further evidence for the role of oxidative stress in MPT is
the associated occurrence of oxidative damage to non-protein
mitochondrial components. Extensive lipid oxidation parallels
MPT when mitochondria are treated with high phosphate
concentrations [41]. Pi stimulates lipid oxidation due to its
ability to catalyze aldehyde tautomerization producing enols,
which, when oxidized by heme proteins, yield triplet state
aldehydes that are ROS themselves [41,52]. Lipid oxidation
is also associated with MPT promoted by peroxynitrate [50].
Lipid oxidation may increase the destructive e¡ects of MPT in
cells, since it also promotes mitochondrial swelling, cyto-
chrome c release and impaired oxidative phosphorylation. In-
deed, the short-term irreversibility of membrane lipid oxida-
tion makes this form of mitochondrial damage potentially
more lethal than MPT, which is reversible soon after its onset
[8].
7. In situ MPT is related to cellular redox state
While most of our data relating MPT to mitochondrial
oxidative stress was collected from isolated organelle studies,
a large amount of experiments using intact cells now support
our conclusions. Cell death under conditions which may in-
volve MPT can be prevented by antioxidants [53^59], while
NAD(P)H oxidants promote mitochondrial oxidative stress
and MPT in intact cells [19,60]. In addition, reduced GSH,
which prevents MPT, has been shown to promote cell survival
after injurious stimuli [58,61^63].
MPT occurring inside cells may be a manner of eliminating
individual mitochondria (‘mitoptosis’) which produce exces-
sive ROS [64]. Thus, MPT may be a last-line cellular defense
mechanism against mitochondrially generated ROS.
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